Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals (AIFSIDDES)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2009 by Liuhuaqiao Hospital.
Recruitment status was:  Recruiting
Information provided by:
Liuhuaqiao Hospital Identifier:
First received: September 8, 2009
Last updated: NA
Last verified: September 2009
History: No changes posted
The purpose of this study is to investigate if there is any different follow-up results by angiography and IVUS between two different drug-eluting stents after implanted simultaneously in same individuals.

Drug Eluting Stent

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Further study details as provided by Liuhuaqiao Hospital:

Primary Outcome Measures:
  • Segment and instent restenosis measured by coronary angiography and IVUS. [ Time Frame: at 12 months after implantation ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Uncovered and malposition of stent. [ Time Frame: at 12 months after implantation. ] [ Designated as safety issue: Yes ]

Estimated Enrollment: 30
Study Start Date: May 2009
Endeavor group and Excel group
Endeavor group: measurements from the vessels implanted Endeavor stent(s). Excel group: measurements from the vessels implanted Excel stent(s).


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Genders Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Inclusion Criteria:

  • These patients who received two kinds of drug-eluting stent (Endeavor and Excel) im simultaneously.

Exclusion Criteria:

  • Dual anti-platelet therapy less than 12 months.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00973375

China, Guangdong
Liuhuaqiao Hospital
Guangzhou, Guangdong, China, 510010
Sponsors and Collaborators
Liuhuaqiao Hospital
  More Information

Responsible Party: Dingcheng Xiang, MD., Ph.D, Liuhuaqiao Hospital Identifier: NCT00973375     History of Changes
Other Study ID Numbers: LHQ09-003 
Study First Received: September 8, 2009
Last Updated: September 8, 2009
Health Authority: China: Ethics Committee

Keywords provided by Liuhuaqiao Hospital:
Drug-eluting stent
coronary restenosis
coronary thrombosis processed this record on January 14, 2017